Samsung Bioepis

84 articles about Samsung Bioepis

• Samsung Bioepis To Present Eight New Abstracts On Three Anti-TNF-? Biosimilar Molecules At The Annual European Congress On Rheumatology (EULAR 2016)

  6/3/2016

• Samsung Bioepis Becomes First To Obtain European Commission Approval For Second Anti-TNF-? Biosimilar With Flixabi

  5/31/2016

• Samsung Bioepis’ Biologics License Application For SB2 Infliximab Biosimilar Accepted By U.S. FDA

  5/24/2016

• Samsung Bioepis Brings in Lawyers to Sue AbbVie in Biosimilars Push

  4/4/2016